{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T15:15:47Z","timestamp":1771427747564,"version":"3.50.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:00:00Z","timestamp":1771372800000},"content-version":"vor","delay-in-days":22,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004761","name":"Natural Science Foundation of Hunan Province of China","doi-asserted-by":"crossref","award":["2024JJ7022"],"award-info":[{"award-number":["2024JJ7022"]}],"id":[{"id":"10.13039\/501100004761","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Guiding Plan Project for Scientific and Technological Innovation in Changde City","award":["2024ZD185"],"award-info":[{"award-number":["2024ZD185"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-026-04488-1","type":"journal-article","created":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T12:28:00Z","timestamp":1769516880000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Integrating transcriptomics and Mendelian randomisation identifies immune-related genes causally linked to prostate cancer lymph node metastasis"],"prefix":"10.1007","volume":"17","author":[{"given":"Shuang","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yizhao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruisong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,27]]},"reference":[{"issue":"10437","key":"4488_CR1","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1016\/S0140-6736(24)00651-2","volume":"403","author":"ND James","year":"2024","unstructured":"James ND, Tannock I, N\u2019Dow J, Feng F, Gillessen S, Ali SA, et al. The lancet commission on prostate cancer: planning for the surge in cases. Lancet. 2024;403(10437):1683\u2013722. https:\/\/doi.org\/10.1016\/S0140-6736(24)00651-2.","journal-title":"Lancet"},{"issue":"1","key":"4488_CR2","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s40164-023-00407-0","volume":"12","author":"S Xin","year":"2023","unstructured":"Xin S, Liu X, Li Z, Sun X, Wang R, Zhang Z, et al. ScRNA-seq revealed an immunosuppression state and tumor microenvironment heterogeneity related to lymph node metastasis in prostate cancer. Exp Hematol Oncol. 2023;12(1):49. https:\/\/doi.org\/10.1186\/s40164-023-00407-0.","journal-title":"Exp Hematol Oncol"},{"key":"4488_CR3","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2022-006020","author":"S Chen","year":"2023","unstructured":"Chen S, Lu K, Hou Y, You Z, Shu C, Wei X, et al. YY1 complex in M2 macrophage promotes prostate cancer progression by upregulating IL-6. J Immunother Cancer. 2023. https:\/\/doi.org\/10.1136\/jitc-2022-006020.","journal-title":"J Immunother Cancer"},{"issue":"11","key":"4488_CR4","doi-asserted-by":"publisher","first-page":"2962","DOI":"10.3390\/cancers15112962","volume":"15","author":"LG Zuur","year":"2023","unstructured":"Zuur LG, de Barros HA, van der Mijn KJC, Vis AN, Bergman AM, Pos FJ, et al. Treating primary Node-Positive prostate cancer: A scoping review of available treatment options. Cancers. 2023;15(11):2962. https:\/\/doi.org\/10.3390\/cancers15112962.","journal-title":"Cancers"},{"issue":"1","key":"4488_CR5","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s12957-024-03344-2","volume":"22","author":"B Dong","year":"2024","unstructured":"Dong B, Zhan H, Luan T, Wang J. The role and controversy of pelvic lymph node dissection in prostate cancer treatment: a focused review. World J Surg Oncol. 2024;22(1):68. https:\/\/doi.org\/10.1186\/s12957-024-03344-2.","journal-title":"World J Surg Oncol"},{"issue":"1","key":"4488_CR6","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s13045-023-01442-4","volume":"16","author":"X Ye","year":"2023","unstructured":"Ye X, Huang X, Fu X, Zhang X, Lin R, Zhang W, et al. Myeloid-like tumor hybrid cells in bone marrow promote progression of prostate cancer bone metastasis. J Hematol Oncol. 2023;16(1):46. https:\/\/doi.org\/10.1186\/s13045-023-01442-4.","journal-title":"J Hematol Oncol"},{"issue":"6","key":"4488_CR7","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.7150\/thno.105276","volume":"15","author":"H Wang","year":"2025","unstructured":"Wang H, Zhou F, Qin W, Yang Y, Li X, Liu R. Metabolic regulation of myeloid-derived suppressor cells in tumor immune microenvironment: targets and therapeutic strategies. Theranostics. 2025;15(6):2159\u201384. https:\/\/doi.org\/10.7150\/thno.105276.","journal-title":"Theranostics"},{"key":"4488_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/biom15060826","author":"Y Wang","year":"2025","unstructured":"Wang Y, Chen Y, Wang J. Role of tumor microenvironment in prostate cancer immunometabolism. Biomolecules. 2025. https:\/\/doi.org\/10.3390\/biom15060826","journal-title":"Biomolecules"},{"issue":"4","key":"4488_CR9","doi-asserted-by":"publisher","first-page":"e1006985","DOI":"10.1371\/journal.ppat.1006985","volume":"14","author":"A Gangaplara","year":"2018","unstructured":"Gangaplara A, Martens C, Dahlstrom E, Metidji A, Gokhale AS, Glass DD, et al. Type I interferon signaling attenuates regulatory T cell function in viral infection and in the tumor microenvironment. PLoS Pathog. 2018;14(4):e1006985. https:\/\/doi.org\/10.1371\/journal.ppat.1006985.","journal-title":"PLoS Pathog"},{"issue":"6","key":"4488_CR10","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1245\/s10434-010-0985-4","volume":"17","author":"SB Edge","year":"2010","unstructured":"Edge SB, Compton CC. The American joint committee on cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol. 2010;17(6):1471\u20134. https:\/\/doi.org\/10.1245\/s10434-010-0985-4.","journal-title":"Ann Surg Oncol"},{"issue":"6589","key":"4488_CR11","doi-asserted-by":"publisher","first-page":"eabf3041","DOI":"10.1126\/science.abf3041","volume":"376","author":"S Yazar","year":"2022","unstructured":"Yazar S, Alquicira-Hernandez J, Wing K, Senabouth A, Gordon MG, Andersen S, et al. Single-cell eQTL mapping identifies cell type\u2013specific genetic control of autoimmune disease. Science. 2022;376(6589):eabf3041. https:\/\/doi.org\/10.1126\/science.abf3041.","journal-title":"Science"},{"key":"4488_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.xinn.2024.100722","author":"G Yu","year":"2024","unstructured":"Yu G. Thirteen years of clusterprofiler. Innovation. 2024. https:\/\/doi.org\/10.1016\/j.xinn.2024.100722.","journal-title":"Innovation"},{"issue":"4","key":"4488_CR13","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1093\/aje\/kwu283","volume":"181","author":"S Burgess","year":"2015","unstructured":"Burgess S, Thompson SG. Multivariable Mendelian randomization: the use of pleiotropic genetic variants to estimate causal effects. Am J Epidemiol. 2015;181(4):251\u201360. https:\/\/doi.org\/10.1093\/aje\/kwu283.","journal-title":"Am J Epidemiol"},{"issue":"3","key":"4488_CR14","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1214\/19-AOS1866","volume":"48","author":"Q Zhao","year":"2020","unstructured":"Zhao Q, Wang J, Hemani G, Bowden J, Small DS. Statistical inference in two-sample summary-data Mendelian randomization using robust adjusted profile score. Annals Stat. 2020;48(3):1742\u201369.","journal-title":"Annals Stat"},{"issue":"11","key":"4488_CR15","doi-asserted-by":"publisher","first-page":"e1007081","DOI":"10.1371\/journal.pgen.1007081","volume":"13","author":"G Hemani","year":"2017","unstructured":"Hemani G, Tilling K, Davey Smith G. Orienting the causal relationship between imprecisely measured traits using GWAS summary data. PLoS Genet. 2017;13(11):e1007081.","journal-title":"PLoS Genet"},{"key":"4488_CR16","doi-asserted-by":"publisher","first-page":"e34408","DOI":"10.7554\/eLife.34408","volume":"7","author":"G Hemani","year":"2018","unstructured":"Hemani G, Zheng J, Elsworth B, Wade KH, Haberland V, Baird D, et al. The MR-Base platform supports systematic causal inference across the human phenome. eLife. 2018;7:e34408. https:\/\/doi.org\/10.7554\/eLife.34408.","journal-title":"eLife"},{"issue":"5","key":"4488_CR17","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s41588-018-0099-7","volume":"50","author":"M Verbanck","year":"2018","unstructured":"Verbanck M, Chen CY, Neale B, Do R. Detection of widespread horizontal Pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases. Nat Genet. 2018;50(5):693\u20138. https:\/\/doi.org\/10.1038\/s41588-018-0099-7.","journal-title":"Nat Genet"},{"issue":"5","key":"4488_CR18","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nmeth.3337","volume":"12","author":"AM Newman","year":"2015","unstructured":"Newman AM, Liu CL, Green MR, Gentles AJ, Feng W, Xu Y, et al. Robust enumeration of cell subsets from tissue expression profiles. Nat Methods. 2015;12(5):453\u20137. https:\/\/doi.org\/10.1038\/nmeth.3337.","journal-title":"Nat Methods"},{"issue":"5","key":"4488_CR19","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1089\/ars.2011.3892","volume":"15","author":"LJ John","year":"2011","unstructured":"John LJ, Fromm M, Schulzke JD Epithelial barriers in intestinal inflammation. Antioxid Redox Signal. 2011;15(5):1255\u201370. https:\/\/doi.org\/10.1089\/ars.2011.3892.","journal-title":"Antioxid Redox Signal"},{"issue":"1","key":"4488_CR20","doi-asserted-by":"publisher","first-page":"2184307","DOI":"10.1080\/10717544.2023.2184307","volume":"30","author":"P Haloi","year":"2023","unstructured":"Haloi P, Lokesh BS, Chawla S, Konkimalla VB. Formulation of a dual drug-loaded nanoparticulate co-delivery hydrogel system and its validation in rheumatoid arthritis animal model. Drug Deliv. 2023;30(1):2184307.","journal-title":"Drug Deliv"},{"key":"4488_CR21","doi-asserted-by":"publisher","first-page":"119770","DOI":"10.1016\/j.lfs.2021.119770","volume":"281","author":"VM Mart\u00edn Gim\u00e9nez","year":"2021","unstructured":"Mart\u00edn Gim\u00e9nez VM, Bergam I, Reiter RJ, Manucha W. Metal ion homeostasis with emphasis on zinc and copper: potential crucial link to explain the non-classical antioxidative properties of vitamin D and melatonin. Life Sci. 2021;281:119770. https:\/\/doi.org\/10.1016\/j.lfs.2021.119770.","journal-title":"Life Sci"},{"issue":"7","key":"4488_CR22","doi-asserted-by":"publisher","first-page":"3673","DOI":"10.1093\/nar\/gkac200","volume":"50","author":"RR Bowers","year":"2022","unstructured":"Bowers RR, Jones CM, Paz EA, Barrows JK, Armeson KE, Long DT, et al. SWAN pathway-network identification of common aneuploidy-based oncogenic drivers. Nucleic Acids Res. 2022;50(7):3673\u201392. https:\/\/doi.org\/10.1093\/nar\/gkac200.","journal-title":"Nucleic Acids Res"},{"issue":"12","key":"4488_CR23","doi-asserted-by":"publisher","first-page":"4121","DOI":"10.7150\/thno.84500","volume":"13","author":"N Huang","year":"2023","unstructured":"Huang N, Qian A, Zou Y, Lin M, Pan W, Chen M, et al. Immunogenic radiation therapy for enhanced anti-tumor immunity via core-shell nanocomposite-mediated multiple strategies. Theranostics. 2023;13(12):4121\u201337. https:\/\/doi.org\/10.7150\/thno.84500.","journal-title":"Theranostics"},{"key":"4488_CR24","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.ijbiomac.2017.02.043","volume":"99","author":"HR Park","year":"2017","unstructured":"Park HR, Hwang D, Suh HJ, Yu KW, Kim TY, Shin KS. Antitumor and antimetastatic activities of rhamnogalacturonan-II-type polysaccharide isolated from mature leaves of green tea via activation of macrophages and natural killer cells. Int J Biol Macromol. 2017;99:179\u201386. https:\/\/doi.org\/10.1016\/j.ijbiomac.2017.02.043.","journal-title":"Int J Biol Macromol"},{"issue":"1","key":"4488_CR25","doi-asserted-by":"publisher","first-page":"e1181","DOI":"10.1002\/ctm2.1181","volume":"13","author":"S Nakamura","year":"2023","unstructured":"Nakamura S, Ohuchida K, Ohtsubo Y, Yamada Y, Tsutsumi C, Okuda S, et al. Single-cell transcriptome analysis reveals functional changes in tumour-infiltrating B lymphocytes after chemotherapy in oesophageal squamous cell carcinoma. Clin Transl Med. 2023;13(1):e1181.","journal-title":"Clin Transl Med"},{"issue":"1","key":"4488_CR26","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s13045-018-0645-x","volume":"11","author":"M Si","year":"2018","unstructured":"Si M, Lang J. The roles of Metallothioneins in carcinogenesis. J Hematol Oncol. 2018;11(1):107. https:\/\/doi.org\/10.1186\/s13045-018-0645-x.","journal-title":"J Hematol Oncol"},{"issue":"2","key":"4488_CR27","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1002\/path.4169","volume":"230","author":"YC Han","year":"2013","unstructured":"Han YC, Zheng ZL, Zuo ZH, Yu YP, Chen R, Tseng GC, et al. Metallothionein 1 h tumour suppressor activity in prostate cancer is mediated by euchromatin methyltransferase 1. J Pathol. 2013;230(2):184\u201393.","journal-title":"J Pathol"},{"issue":"6","key":"4488_CR28","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1016\/j.bbadis.2012.02.021","volume":"1822","author":"D-W Yan","year":"2012","unstructured":"Yan D-W, Fan J-W, Yu Z-h, Li M-x, Wen Y-G, Li D-W, et al. Downregulation of Metallothionein 1F, a putative oncosuppressor, by loss of heterozygosity in colon cancer tissue. Biochim Biophys Acta (BBA) - Mol Basis Dis. 2012;1822(6):918\u201326. https:\/\/doi.org\/10.1016\/j.bbadis.2012.02.021.","journal-title":"Biochim Biophys Acta (BBA) - Mol Basis Dis"},{"issue":"6","key":"4488_CR29","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1158\/1078-0432.Ccr-06-2492","volume":"13","author":"S Feng","year":"2007","unstructured":"Feng S, Agoulnik IU, Bogatcheva NV, Kamat AA, Kwabi-Addo B, Li R, et al. Relaxin promotes prostate cancer progression. Clin Cancer Res. 2007;13(6):1695\u2013702. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-06-2492.","journal-title":"Clin Cancer Res"},{"issue":"4","key":"4488_CR30","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1677\/erc-10-0073","volume":"17","author":"S Feng","year":"2010","unstructured":"Feng S, Agoulnik IU, Truong A, Li Z, Creighton CJ, Kaftanovskaya EM, et al. Suppression of relaxin receptor RXFP1 decreases prostate cancer growth and metastasis. Endocr Relat Cancer. 2010;17(4):1021\u201333. https:\/\/doi.org\/10.1677\/erc-10-0073.","journal-title":"Endocr Relat Cancer"},{"issue":"1","key":"4488_CR31","doi-asserted-by":"publisher","first-page":"2993","DOI":"10.1038\/s41467-019-10893-8","volume":"10","author":"M Hu","year":"2019","unstructured":"Hu M, Wang Y, Xu L, An S, Tang Y, Zhou X, et al. Relaxin gene delivery mitigates liver metastasis and synergizes with check point therapy. Nat Commun. 2019;10(1):2993. https:\/\/doi.org\/10.1038\/s41467-019-10893-8.","journal-title":"Nat Commun"},{"key":"4488_CR32","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abb6596","author":"X Zhou","year":"2021","unstructured":"Zhou X, Liu Y, Hu M, Wang M, Liu X, Huang L. Relaxin gene delivery modulates macrophages to resolve cancer fibrosis and synergizes with immune checkpoint blockade therapy. Sci Adv. 2021. https:\/\/doi.org\/10.1126\/sciadv.abb6596.","journal-title":"Sci Adv"},{"issue":"6","key":"4488_CR33","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1016\/j.eururo.2021.01.017","volume":"79","author":"C Guo","year":"2021","unstructured":"Guo C, Crespo M, Gurel B, Dolling D, Rekowski J, Sharp A, et al. CD38 in advanced prostate cancers. Eur Urol. 2021;79(6):736\u201346. https:\/\/doi.org\/10.1016\/j.eururo.2021.01.017.","journal-title":"Eur Urol"},{"issue":"1","key":"4488_CR34","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/s41556-020-00613-6","volume":"23","author":"S Chen","year":"2021","unstructured":"Chen S, Zhu G, Yang Y, Wang F, Xiao Y-T, Zhang N, et al. Single-cell analysis reveals transcriptomic remodellings in distinct cell types that contribute to human prostate cancer progression. Nat Cell Biol. 2021;23(1):87\u201398. https:\/\/doi.org\/10.1038\/s41556-020-00613-6.","journal-title":"Nat Cell Biol"},{"issue":"1","key":"4488_CR35","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s41467-021-27322-4","volume":"13","author":"H Song","year":"2022","unstructured":"Song H, Weinstein HNW, Allegakoen P, Wadsworth MH, Xie J, Yang H, et al. Single-cell analysis of human primary prostate cancer reveals the heterogeneity of tumor-associated epithelial cell States. Nat Commun. 2022;13(1):141. https:\/\/doi.org\/10.1038\/s41467-021-27322-4.","journal-title":"Nat Commun"},{"issue":"6","key":"4488_CR36","doi-asserted-by":"publisher","first-page":"e50162","DOI":"10.15252\/embr.202050162","volume":"21","author":"KL Owen","year":"2020","unstructured":"Owen KL, Gearing LJ, Zanker DJ, Brockwell NK, Khoo WH, Roden DL, et al. Prostate cancer cell-intrinsic interferon signaling regulates dormancy and metastatic outgrowth in bone. EMBO Rep. 2020;21(6):e50162. https:\/\/doi.org\/10.15252\/embr.202050162.","journal-title":"EMBO Rep"},{"issue":"11","key":"4488_CR37","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1016\/j.ccell.2024.09.010","volume":"42","author":"C Galassi","year":"2024","unstructured":"Galassi C, Chan TA, Vitale I, Galluzzi L. The hallmarks of cancer immune evasion. Cancer Cell. 2024;42(11):1825\u201363. https:\/\/doi.org\/10.1016\/j.ccell.2024.09.010.","journal-title":"Cancer Cell"},{"issue":"1","key":"4488_CR38","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/s41467-023-36325-2","volume":"14","author":"T Hirz","year":"2023","unstructured":"Hirz T, Mei S, Sarkar H, Kfoury Y, Wu S, Verhoeven BM, et al. Dissecting the immune suppressive human prostate tumor microenvironment via integrated single-cell and Spatial transcriptomic analyses. Nat Commun. 2023;14(1):663. https:\/\/doi.org\/10.1038\/s41467-023-36325-2.","journal-title":"Nat Commun"},{"issue":"1","key":"4488_CR39","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s40779-024-00526-7","volume":"11","author":"D-C Feng","year":"2024","unstructured":"Feng D-C, Zhu W-Z, Wang J, Li D-X, Shi X, Xiong Q, et al. The implications of single-cell RNA-seq analysis in prostate cancer: unraveling tumor heterogeneity, therapeutic implications and pathways towards personalized therapy. Military Med Res. 2024;11(1):21. https:\/\/doi.org\/10.1186\/s40779-024-00526-7.","journal-title":"Military Med Res"},{"issue":"1","key":"4488_CR40","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s12916-022-02246-y","volume":"20","author":"G Markozannes","year":"2022","unstructured":"Markozannes G, Kanellopoulou A, Dimopoulou O, Kosmidis D, Zhang X, Wang L, et al. Systematic review of Mendelian randomization studies on risk of cancer. BMC Med. 2022;20(1):41. https:\/\/doi.org\/10.1186\/s12916-022-02246-y.","journal-title":"BMC Med"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-026-04488-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-04488-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-04488-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T14:28:30Z","timestamp":1771424910000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-026-04488-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,27]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4488"],"URL":"https:\/\/doi.org\/10.1007\/s12672-026-04488-1","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,27]]},"assertion":[{"value":"4 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. This study exclusively analyzed publicly available de-identified data from TCGA, FinnGen, and GEO databases, which does not require additional ethical approval. No direct participant involvement as this study analyzed existing public datasets only.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable. No individual participant data, images, or identifiable information are presented in this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"344"}}